Close Menu

NEW YORK – Becton Dickinson reported Thursday that its fiscal first quarter 2021 earnings rose 26 percent year over year attributed in part to $867 million in COVID-19 diagnostic sales.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.